Blood laboratory findings in patients suffering from self-perceived electromagnetic hypersensitivity (EHS)
Norbert Dahmen
Department of Psychiatry, University of Mainz, Germany
Search for more papers by this authorCorresponding Author
David Ghezel-Ahmadi
Department of Psychiatry, University of Mainz, Germany
Department of Psychiatry, University of Mainz, Untere Zahlbacher Straße 8, 55131 Mainz, Germany.Search for more papers by this authorAlice Engel
Department of Psychiatry, University of Mainz, Germany
Search for more papers by this authorNorbert Dahmen
Department of Psychiatry, University of Mainz, Germany
Search for more papers by this authorCorresponding Author
David Ghezel-Ahmadi
Department of Psychiatry, University of Mainz, Germany
Department of Psychiatry, University of Mainz, Untere Zahlbacher Straße 8, 55131 Mainz, Germany.Search for more papers by this authorAlice Engel
Department of Psychiatry, University of Mainz, Germany
Search for more papers by this authorAbstract
Risks from electromagnetic devices are of considerable concern. Electrohypersensitive (EHS) persons attribute a variety of rather unspecific symptoms to exposure to electromagnetic fields. The pathophysiology of EHS is unknown and therapy remains a challenge. We hypothesized that some electrosensitive individuals are suffering from common somatic health problems. Toward this end we analysed clinical laboratory parameters including thyroid-stimulating hormone (TSH), alanine transaminase (ALT), aspartate transaminase (AST), creatinine, hemoglobine, hematocrit and c-reactive protein (CRP) in subjects suffering from EHS and in controls that are routinely used in clinical medicine to identify or screen for common somatic disorders. One hundred thirty-two patients (n = 42 males and n = 90 females) and 101 controls (n = 34 males and n = 67 females) were recruited. Our results identified laboratory signs of thyroid dysfunction, liver dysfunction and chronic inflammatory processes in small but remarkable fractions of EHS sufferers as potential sources of symptoms that merit further investigation in future studies. In the cases of TSH and ALT/AST there were significant differences between cases and controls. The hypotheses of anaemia or kidney dysfunction playing a major role in EHS could be unambiguously refuted. Clinically it is recommended to check for signs of treatable somatic conditions when caring for individuals suffering from self-proclaimed EHS. Bioelectromagnetics 30:299–306, 2009. © 2009 Wiley-Liss, Inc.
REFERENCES
- Akdag MZ, Dasdag S, Aksen F, Isik B, Yilmaz F. 2006. Effect of ELF magnetic fields on lipid peroxidation, sperm count, p53, and trace elements. Med Sci Monit 12(11): BR366–BR371.
- Banerjee RN, Narang RM. Haematological changes in malignancy. 1967. Br J Haematol 13(6): 829–843.
- Berg M. 1988. Skin problems in workers using visual display terminals. Contact Dermat 19: 335–341.
- Berg M, Lidén S, Axelson O. 1990. Facial complaints and work at visual display units. J Am Acad Dermatol 22: 621–625.
- Bergamaschi A, Magrini A, Ales G, Coppeta L, Somma G. 2004. Are thyroid dysfunctions related to stress or microwave exposure (900 MHz)? Int J Immunopathol Pharmacol 17 (2 Suppl): 31–36.
- Bergdahl J. 1995. Psychological aspects of patients with symptoms presumed to be caused by electricity or visual display units. Acta Ondotol Scand 53: 304–310.
- U Bergqvist, E Vogel, editors. 1997. Possible health implications of subjective symptoms and electromagnetic fields: A report by a European group of experts for the European Commission. Solna/Sweden: Directorate-General V. National Institute for. Working Life.
- Bergqvist U, Wahlberg JE. 1994. Skin symptoms and disease during work with visual display terminals. Contact Dermat 30: 197–204.
- Boscolo P, Di Gioacchino M, Di Giampaolo L, Antonucci A, Di Luzio S. 2007. Combined effects of electromagnetic fields on immune and nervous responses. Int J Immunopathol Pharmacol 20 (2 Suppl 2): 59–63.
- Carpenter DO, Sage C. 2008. Setting prudent public health policy for electromagnetic field exposures. Rev Environ Health 23(2): 91–117.
- Cartwright GE. 1966. The anemia of chronic disorders. Semin Hematol 3(4): 351–375.
- Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. 1998. Fatigue in primary biliary cirrhosis. Gut 43(5): 705–710.
- Danese S, Motte Cd Cde L, Fiocchi C. 2004. Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 99(5): 938–945.
- Dasdag S, Sert C, Akdag Z, Batun S. 2002. Effects of extremely low frequency electromagnetic fields on hematologic and immunologic parameters in welders. Arch Med Res 33(1): 29–32.
- Djeridane Y, Touitou Y, de Seze R. 2008. Influence of electromagnetic fields emitted by GSM-900 cellular telephones on the circadian patterns of gonadal, adrenal and pituitary hormones in men. Radiat Res 169(3): 337–343.
- Frick U, Rehm J, Eichhammer P. 2002. Risk perception, somatization, and self report of complaints related to electromagnetic fields–a randomized survey study. Int J Hyg Environ Health 205(5): 353–360.
- Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. 2006. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 37(1): 133–139.
- Hachulla E, Caulier-Leleu MT, Fontaine O, Mehianoui L, Pelerin P. 2000. Pseudo-iron deficiency in a French population living near high-voltage transmission lines: A dilemma for clinicians. Eur J Intern Med 11(6): 351–352.
- Hietanen M, Hämäläinen AM, Husman T. 2002. Hypersensitivity symptoms associated with exposure to cellular telephones: No causal link. Bioelectromagnetics 23(4): 264–270.
- Hillert L, Hedman BK, Söderman E, Arnetz BB. 1999. Hypersensitivity to electricity: Working definition and additional characterization of the syndrome. Psychosom Res 47(5): 429–438.
- Hillert L, Berglind N, Arnetz BB, Bellander T. 2002. Prevalence of self-reported hypersensitivity to electric or magnetic fields in a population-based questionnaire survey. Scand J Work Environ Health 28: 33–41.
- Knave B. 2001. Electromagnetic fields and health outcomes. Ann Acad Med Singapore 30(5): 489–493.
- Kumar D, Tandon RK. 2002. Fatigue in cholestatic liver disease—A perplexing symptom. Postgrad Med J 78(921): 404–407.
- Leclercq I, Horsmans Y, De Bruyere M, Geubel AP. 1999. Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors. Acta Gastroenterol Belg 62(1): 16–20.
- Leitgeb N, Schröttner J. 2003. Electrosensibility and electromagnetic hypersensitivity. Bioelectromagnetics 24(6): 387–394.
- Lindén V. 1981. Video computer terminals and occupational dermatitis. Scand J Work Environ Health 7: 62–67.
- Lonne-Rahm S, Andersson B, Melin L, Schultzberg M, Arnetz B, Berg M. 2000. Provocation with stress and electricity of patients with “sensitivity to electricity”. J Occup Environ Med 42: 512–516.
- Markgraf J. 1994. Mini-DIPS—Handbuch [revised by Jacobs S, Krampe H and Wagner T.]. Berlin: Springer.
- Murtagh FE, Addington-Hall J, Higginson IJ. 2007. The prevalence of symptoms in end-stage renal disease: A systematic review. Adv Chronic Kidney Dis 14(1): 82–99.
- Nilsen A. 1982. Facial rash in visual display unit operators. Contact Dermat 8: 25–28.
- Röösli M. 2008. Radiofrequency electromagnetic field exposure and non-specific symptoms of ill health: A systematic review. Environ Res 107(2): 277–287.
- Röösli M, Moser M, Baldinini Y, Meier M, Braun-Fahrländer C. 2004. Symptoms of ill health ascribed to electromagnetic field exposure—A questionnaire survey. Int J Hyg Environ Health 207(2): 141–150.
- Salive ME, Jones CA, Guralnik JM, Agodoa LY, Pahor M, Wallace RB. 1995. Serum creatinine levels in older adults: Relationship with health status and medications. Age Ageing 24(2): 142–150.
- Schüz J, Petters C, Egle UT, Jansen B, Kimbel R, Letzel S, Nix W, Schmidt LG, Vollrath L. 2006. The “Mainzer EMF-Wachhund”: Results from a watchdog project on self-reported health complaints attributed to exposure to electromagnetic fields. Bioelectromagnetics 27(4): 280–287.
- Seitz H, Stinner D, Eikmann T, Herr C, Röösli M. 2005. Electromagnetic hypersensitivity (EHS) and subjective health complaints associated with electromagnetic fields of mobile phone communication—A literature review published between 2000 and 2004. Sci Total Environ 349(1–3): 45–55.
- Selmaoui B, Lambrozo J, Touitou Y. 1996. Magnetic fields and pineal function in humans: Evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci 58(18): 1539–1549.
- Silny J, Meyer M, Wiesmüller GA, Dott W. 2004. Health effects from radiofrequency electromagnetic fields of mobile phones and other new communication systems. Umwelt Med Forsch Prax 9(3): 127–136.
- Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff J. 1987. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33(8): 1391–1396.
- Suwalska A, Lacka K, Lojko D, Rybakowski JK. 2005. Quality of life, depressive symptoms and anxiety in hyperthyroid patients. Annales Academiae Medicae Bialostocensis 50 (Suppl 1): 61–63.
- Swain MG. 2006. Fatigue in liver disease: Pathophysiology and clinical management. Can J Gastroenterol 20(3): 181–188.
- WHO. 2004. Workshop on electromagnetic hypersensitivity. October 25–27, Prague, Czech Republic: World Health Organization. Available from: http://www.who.int/peh-emf/publications/reports/EHS_Proceedings_June2006.pdf [Last updated June 2006].
- WHO. 2006. Iron Deficiency Anaemia [Internet]. Geneva (CH): World Health Organization. Available from: http://www. who.int/reproductive-health/docs/anaemia.pdf [Last updated 10 July 2006].
- Wish JB. 2006. Assessing iron status: Beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 1 (Suppl 1): S4–S8.